Cayson Acquisition Corp Ordinary shares (CAPN NASDAQ) stock market data APIs
$10.3556
0(0%)
as of July 3, 2025
Try our APIs with
free plan!
Cayson Acquisition Corp Ordinary shares Financial Data Overview
Price chart is built with
Anychart
Cayson Acquisition Corp does not have significant operations. It intends to effect a merger, stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses or entities. The company was incorporated in 2024 and is based in New York, New York.
Prev. Close
10.3556
Open
10.3556
High
10.3556
Low
10.3556
52 wk Range
9.95-10.47
Market Cap
80 179 K
Shares Outstanding
7 830 K
EPS
0.0517
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Cayson Acquisition Corp Ordinary shares data using free add-ons & libraries
Get Cayson Acquisition Corp Ordinary shares Fundamental Data
Cayson Acquisition Corp Ordinary shares Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-05-07
- EPS/Forecast: NaN
Get Cayson Acquisition Corp Ordinary shares End-of-day data
EOD Historical Data package for
$
19.99
/mo.
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Cayson Acquisition Corp Ordinary shares News
New
Capnia Provides Corporate Update and Reports First Quarter 2017 Financial Results
Completed merger with Essentialis, Inc. and concurrent financing of $10 million New company name, Soleno Therapeutics, Inc., to reflect new strategic focus on rare disease therapeutics; stock to trade...
Capnia Reports Fourth Quarter and Full Year 2016 Financial Results
REDWOOD CITY, Calif., March 15, 2017 (GLOBE NEWSWIRE) -- Capnia, Inc. (NASDAQ:CAPN), focused on the development and commercialization of novel therapeutics for the treatment of rare diseases, today ...
Capnia Completes Merger with Essentialis Creating Rare Disease Therapeutics Company
Lead Clinical Asset Entering Phase II/III Development in 2017 for the Treatment of Prader-Willi Syndrome Raises $10 Million in Concurrent Financing; Cash Runway Through Key Milestones REDWOOD CITY, ...
Capnia to Present at the 19th Annual BIO CEO & Investor Conference
REDWOOD CITY, Calif., Feb. 07, 2017 (GLOBE NEWSWIRE) -- Capnia, Inc. (NASDAQ:CAPN), a diversified healthcare company that develops and commercializes innovative diagnostics, devices and therapeutics...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
